General science PCOS Renamed as PMOS Context : A global medical consensus led by the Endocrine Society has renamed Polycystic Ovary Syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS) after extensive scientific consultations. PMOS is a multisystem endocrine-metabolic disorder affecting hormonal balance, metabolism, reproductive health, and mental well-being in women of reproductive age. It affects around 1 in 8 women globally and is a leading cause of infertility and menstrual irregularities. Major health risks include insulin resistance leading to Type 2 diabetes, cardiovascular diseases (hypertension, heart disease), and psychological disorders such as anxiety and depression. Diagnosis is based on at least two of three criteria: Irregular or absent ovulation Hyperandrogenism (clinical or biochemical signs) Polycystic ovarian morphology or hormonal markers Studies show that up to 70% of cases remain undiagnosed, due to lack of awareness and misleading terminology.
